Novo Integrated Sciences
NVOS
#10601
Rank
โ‚ฌ0.03 M
Marketcap
0,001804ย โ‚ฌ
Share price
110.00%
Change (1 day)
-96.82%
Change (1 year)

Revenue for Novo Integrated Sciences (NVOS)

Revenue in 2024 (TTM): โ‚ฌ12.42 Million

According to Novo Integrated Sciences's latest financial reports the company's current revenue (TTM ) is โ‚ฌ11.61 Million. In 2023 the company made a revenue of โ‚ฌ11.79 Million an increase over the revenue in the year 2022 that were of โ‚ฌ11.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novo Integrated Sciences from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ12.42 M5.28%
2023 โ‚ฌ11.79 M5.52%
2022 โ‚ฌ11.18 M22.82%
2021 โ‚ฌ9.1 M49.97%
2020 โ‚ฌ6.07 M-29.59%
2019 โ‚ฌ8.62 M10.18%
2018 โ‚ฌ7.82 M43.04%
2017 โ‚ฌ5.47 M
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Select Medical Holdings
SEM
โ‚ฌ3.37 B 29,001.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Integrated Sciences
NVOS
โ‚ฌ11.61 M 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HealthSouth
EHC
โ‚ฌ4.97 B 42,776.51%๐Ÿ‡บ๐Ÿ‡ธ USA